Tandem Diabetes Care, Inc. (TNDM)
22.22
-0.10
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
22.18
-0.04
(-0.18%)
After-Hours: 20:00
Tandem Diabetes Care Gross Profit Margin (Quarterly) : 56.80% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.80% |
| March 31, 2026 | 55.34% |
| December 31, 2025 | 57.66% |
| September 30, 2025 | 53.88% |
| June 30, 2025 | 52.29% |
| March 31, 2025 | 50.51% |
| December 31, 2024 | 55.71% |
| September 30, 2024 | 51.09% |
| June 30, 2024 | 50.83% |
| March 31, 2024 | 49.39% |
| December 31, 2023 | 47.41% |
| September 30, 2023 | 48.35% |
| June 30, 2023 | 51.93% |
| March 31, 2023 | 48.95% |
| December 31, 2022 | 52.39% |
| September 30, 2022 | 51.05% |
| June 30, 2022 | 50.91% |
| March 31, 2022 | 51.78% |
| December 31, 2021 | 54.16% |
| September 30, 2021 | 54.19% |
| June 30, 2021 | 54.13% |
| March 31, 2021 | 52.06% |
| December 31, 2020 | 54.38% |
| September 30, 2020 | 53.37% |
| June 30, 2020 | 49.79% |
| Date | Value |
|---|---|
| March 31, 2020 | 51.33% |
| December 31, 2019 | 55.60% |
| September 30, 2019 | 53.54% |
| June 30, 2019 | 53.51% |
| March 31, 2019 | 50.54% |
| December 31, 2018 | 54.51% |
| September 30, 2018 | 47.11% |
| June 30, 2018 | 44.21% |
| March 31, 2018 | 47.94% |
| December 31, 2017 | 43.35% |
| September 30, 2017 | 49.68% |
| June 30, 2017 | 43.20% |
| March 31, 2017 | 35.59% |
| December 31, 2016 | 34.81% |
| September 30, 2016 | -12.83% |
| June 30, 2016 | 35.57% |
| March 31, 2016 | 34.54% |
| December 31, 2015 | 46.22% |
| September 30, 2015 | 35.08% |
| June 30, 2015 | 30.57% |
| March 31, 2015 | 22.81% |
| December 31, 2014 | 36.53% |
| September 30, 2014 | 32.54% |
| June 30, 2014 | 33.63% |
| March 31, 2014 | 10.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DexCom, Inc. | 63.44% |
| Modular Medical, Inc. | -- |
| Senseonics Holdings, Inc. | 59.10% |
| NeuroPace, Inc. | 82.83% |
| Abbott Laboratories | 52.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -46.27% |
| Return on Assets | -6.41% |
| Return on Invested Capital | -9.03% |
| Profit Margin (Quarterly) | -8.33% |
| Operating Margin (Quarterly) | -5.59% |
| Return on Net Operating Assets | -13.55% |